Comparison of Age-Related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial - Related Studies

Comparison of Age-Related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial

This study is currently recruiting participants.

Study NCT00593450. Last updated on November 10, 2008. Information provided by National Eye Institute (NEI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Age Related Macular Degeneration

2	Additional conditions recognized in this trial
		Macular Degeneration

3	More general conditions related to this trial
		Eye Diseases
		Retinal Degeneration
		Retinal Diseases

4	Interventions listed in this trial
		ranibizumab
		bevacizumab

5	More general drug interventions related to this trial
		Angiogenesis Inhibitors
		Angiogenesis Modulating Agents
		Antineoplastic Agents
		Growth Inhibitors
		Growth Substances
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		National Eye Institute (NEI)